ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2559

Effect Of NOX4 Overexpression On The Levels Of Micro RNAs Relevant To Systemic Sclerosis Fibrotic Process

Sonsoles Piera-Velazquez, Alma Makul and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center,Thomas Jefferson University, Philadelphia, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: fibroblasts and systemic sclerosis, Gene Expression, MicroRNA, ROS

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud's II

Session Type: Abstract Submissions (ACR)

 Background/Purpose: Systemic sclerosis (SSc) is characterized by the excessive deposition of collagen and other connective tissue components in skin and multiple internal organs.  Although transforming growth factor β (TGF-β) has been shown to play a crucial role in the development of tissue fibrosis in SSc, recently, other factors such as excessive oxidative stress have been implicated in the pathogenesis of the disease. Oxidative stress is caused by cellular overproduction of ROS (reactive oxidative species). NOX4 is one of seven NADPH isoforms which plays a crucial role in the generation of ROS. Numerous recent studies have described an important role of microRNAs (miRNA) in the pathogenesis of the fibrotic process in various fibrotic diseases including renal, pulmonary, and liver fibrosis as well as in SSc. The purpose of these studies was to induce overexpression of NOX4 in normal human dermal fibroblasts and to examine the effect of increased NOX4 levels on the expression of various miRNA that participate in the regulation of tissue fibrosis.

Methods: Two different cell lines of normal human dermal fibroblasts were isolated from skin biopsies, and were expanded in monolayer cultures to approximately 70% of confluence and then they were transiently transfected with either a NOX4 protein expression construct (pCI-NOX4) to induce in NOX4 expression or with the vector control pCI. The effects of NOX4 overexpression on global gene expression levels and on the expression of relevant miRNA were examined employing microarrays using Human gene 1.0 ST array Affymetrix gene chips.

 

Results: Induced NOX4 expression did not cause apparent morphological changes or cytotoxicity. Remarkable changes in the expression levels of numerous transcripts associated with the phenotypic activation of fibroblasts into myofibroblasts were observed. Also, NOX4 overexpression caused significant changes in the levels of several relevant miRNAs. It was of substantial interest that the predicted gene targets for these miRNA included highly relevant genes such as those encoding members of the TGF-β pathway, as well as genes encoding numerous ECM proteins, and several crucial regulatory/transcription factor genes including Fli1, Gli3, and Hif1A.

Conclusion: Induced NOX4 expression resulted in remarkable changes in the levels of expression of numerous transcripts associated with the phenotypic activation of myofibroblasts as well as changes in the levels of several miRNAs that exert important regulatory effects on various genes that participate in the fibrotic process. These observations provide strong support to the notion that targeting NOX4 expression may be a novel therapeutic approach for SSc and other systemic fibrotic disorders.


Disclosure:

S. Piera-Velazquez,
None;

A. Makul,
None;

S. A. Jimenez,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-nox4-overexpression-on-the-levels-of-micro-rnas-relevant-to-systemic-sclerosis-fibrotic-process/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology